Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants

Clinical trial NCT04027387 · COMPLETED

Trial details

NCT number: NCT04027387
Sponsor: TaiMed Biologics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2019-12-14
Primary completion: 2021-08-18
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.